Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

Samlyn Capital, LLC reported a 9.80% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Samlyn Capital, LLC reported a 9.80% stake in Corvus Pharmaceuticals, Inc., 6,667,105 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
9.80%
Shares
6,667,105
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Samlyn Capital, LLC9.80%6,667,105
Samlyn, LP9.80%6,667,105
Robert Pohly9.80%6,667,105

Source

View original at SEC

Related